Re: "DR's 'expectation' of FDA approval in Q2 might have been enough to stave off sub-one dollar PPS, but now that that time has passed, what's to stop a drop to .70?"
You raise good points. Chart shows that after 06/08 FDA report quashed approval hopes, CTGI faded. Following 07/06 FDA disappointment, stock fell further. Arguably, stony silence of a reputedly underfunded, overworked bureaucracy massaged price to these low levels.
Re: "...what's to stop a drop to .70?"
Awaited news of CE mark for handset(s) could quickly reverse the slide and make $1.01 per share look like 25cent Cappuccino Day at Starbucks.
These are my opinions only. Do your DD. Buying stocks is risky.
"If we could sell our experiences for what they cost us, we'd all be millionaires." -Abigail van Buren (a/k/a Dear Abby)